Treatment outcome variation between depression symptom combinations in the STAR*D study

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Major depressive disorder (MDD) exhibits significant symptom and subtype heterogeneity.
• Previous research highlights variability in depression presentations.
• Understanding this heterogeneity is crucial for effective treatment.

Purpose of the Study:

• To explore heterogeneity in depression using data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.
• To test if citalopram treatment outcomes differ based on depression symptom combinations.

Main Methods:

• Employed combinatorial algorithms, latent profile analysis, and repeated-measures multivariate analysis of variance.
• Analyzed prevalent symptom combinations from the STAR*D dataset.
• Characterized heterogeneity and outcome variability.

Main Results:

• Descriptive analyses confirmed substantial heterogeneity in MDD.
• Latent profile analysis revealed distinct treatment outcome patterns among participants.
• A significant interaction between symptom combination and outcome measure profile was found for clinician-rated symptoms.

Conclusions:

• Citalopram treatment outcomes are influenced by specific diagnostic combinations.
• Depression symptom heterogeneity may have implications for prognosis and treatment success.
• Findings support the view that depression is not a homogenous syndrome.